GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Pretax Margin %

Clearmind Medicine (Clearmind Medicine) Pretax Margin % : % (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Clearmind Medicine's Pre-Tax Income for the three months ended in Jan. 2024 was $-1.17 Mil. Clearmind Medicine's Revenue for the three months ended in Jan. 2024 was $0.00 Mil. Therefore, Clearmind Medicine's pretax margin for the quarter that ended in Jan. 2024 was %.

The historical rank and industry rank for Clearmind Medicine's Pretax Margin % or its related term are showing as below:


CMND's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.275
* Ranked among companies with meaningful Pretax Margin % only.

Clearmind Medicine Pretax Margin % Historical Data

The historical data trend for Clearmind Medicine's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Pretax Margin % Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Pretax Margin %
Get a 7-Day Free Trial - - - - -

Clearmind Medicine Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Clearmind Medicine's Pretax Margin %

For the Biotechnology subindustry, Clearmind Medicine's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's Pretax Margin % falls into.



Clearmind Medicine Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Clearmind Medicine's Pretax Margin for the fiscal year that ended in Oct. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Oct. 2023 )/Revenue (A: Oct. 2023 )
=-6.221/0
= %

Clearmind Medicine's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-1.166/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clearmind Medicine  (NAS:CMND) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Clearmind Medicine Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (Clearmind Medicine) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.